Article Text

Download PDFPDF
Restricted use of albumin for spontaneous bacterial peritonitis
  1. Samuel H Sigal1,
  2. Carmen M Stanca1,
  3. Javier Fernandez2,
  4. Vicente Arroyo2,
  5. Miguel Navasa2
  1. 1Division of Liver Disease, Mount Sinai School of Medicine, New York, USA
  2. 2Liver Unit, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
  1. Correspondence to:
    Dr Samuel H Sigal th
    Center for Liver Disease and Transplantation, New York Weill Cornell Medical Center, 525 East 68 Street, Box# 308, New York, New York 10021;shs2015{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Spontaneous bacterial peritonitis (SBP) may precipitate deterioration of circulatory function with severe hepatic insufficiency, hepatic encephalopathy, and type-1 hepatorenal syndrome (HRS) and has 30% hospital mortality despite infection resolution.1 Predictors of this acute-on-chronic liver failure include ascitic fluid concentrations of granulocytes and cytokines and renal and hepatic insufficiency at diagnosis.1–,3 Endotoxemia and the inflammatory response precipitate renal failure (RF) by accentuating splanchnic vasodilatation and impairing cardiac function.3–,5 Compensatory activation of the renin-angiotensin and sympathetic nervous systems further decrease renal perfusion. Volume expansion with albumin (1.5 g/kg day one, 1 g/kg day three) significantly reduces the incidence of HRS and hospital mortality.2

In the sole reported trial, only patients with serum bilirubin (bili) >68.4 μmol/l, blood urea nitrogen (BUN) >30 mg/dl or serum creatinine (Cr) >88.4 μmol/l …

View Full Text


  • Competing interests: None.